Understanding Lymphoma Clinical Trial Participation
This observational study aims to understand why some people with lymphoma choose to join or complete clinical trials, while others do not. Researchers will collect a wide range of information about the experiences of lymphoma patients in clinical trials. The goal is to identify factors that might make it harder for certain groups of people to participate or finish a trial. By looking at trends across different demographic groups, this study hopes to provide insights that can help future lymphoma patients access and complete clinical research. You can join if you are 18 or older with a confirmed lymphoma diagnosis and are able to follow study requirements. The study will measure how many patients decide to enroll in a lymphoma clinical trial after 3 months, and how many stay in the study until it's finished after 12 months.
- Study design
- This is an observational study planning to enroll 500 participants. It is not testing a new treatment, but rather observing experiences.
- What's involved
- You must be willing and able to comply with scheduled visits, laboratory tests, and other requirements of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track participants for up to 12 months to see if they complete the clinical study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Navigating the Clinical Research Process for Lymphoma
At a glance
Conditions
NCT06070246
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Power Life Sciences
San Francisco, Californiastudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Rate of patients who decide to enroll in a lymphoma clinical research.3 months
- Number of lymphoma study participants who remain in clinical study until completion.12 months